FESTARI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 151
EU - Europa 122
AS - Asia 108
SA - Sud America 1
Totale 382
Nazione #
US - Stati Uniti d'America 151
SG - Singapore 51
DE - Germania 36
CN - Cina 29
CZ - Repubblica Ceca 25
IT - Italia 18
TR - Turchia 13
HK - Hong Kong 8
UA - Ucraina 8
FI - Finlandia 7
PL - Polonia 7
RU - Federazione Russa 5
GB - Regno Unito 4
VN - Vietnam 4
BE - Belgio 2
IE - Irlanda 2
LV - Lettonia 2
PT - Portogallo 2
SE - Svezia 2
EC - Ecuador 1
FR - Francia 1
ID - Indonesia 1
JP - Giappone 1
KG - Kirghizistan 1
NO - Norvegia 1
Totale 382
Città #
Singapore 42
Fairfield 20
Olomouc 15
Boardman 14
Ashburn 13
Istanbul 13
Brno 10
Houston 10
Woodbridge 9
Hong Kong 8
Munich 8
Helsinki 7
Romola 7
Cambridge 6
Chandler 6
Jacksonville 6
Seattle 6
Shanghai 6
Warsaw 6
Brescia 5
Dearborn 5
Wilmington 5
Dong Ket 4
New York 4
Princeton 4
Beijing 3
Santa Clara 3
Brussels 2
Des Moines 2
Dublin 2
Leipzig 2
Riga 2
Ann Arbor 1
Bishkek 1
Guayaquil 1
Hangzhou 1
Hebei 1
Jakarta 1
Jinan 1
Kunming 1
Lisbon 1
Los Angeles 1
Miami Beach 1
Nanjing 1
Norwalk 1
Nürnberg 1
Oslo 1
San Diego 1
San Francisco 1
Stockholm 1
Tianjin 1
Tokyo 1
Treviolo 1
Walnut 1
Washington 1
Wenzhou 1
Totale 279
Nome #
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 137
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly 80
Comparison of visual criteria for amyloid-pet reading: Could criteria merging reduce inter-rater variability? 21
Automatic multispectral MRI segmentation of human hippocampal subfields: an evaluation of multicentric test-retest reproducibility 20
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia 14
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus 14
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders 13
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia 13
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease 12
Clinical utility of FDG-PET for the clinical diagnosis in MCI 12
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease 11
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia 11
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia 11
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe 10
Medial temporal lobe atrophy and posterior atrophy scales normative values 10
Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET 9
Totale 398
Categoria #
all - tutte 2.974
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.974


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030 0 0 0 0 3 8 6 4 3 4 0 2
2020/202140 0 2 0 2 0 1 1 6 9 9 6 4
2021/202218 3 1 0 2 0 2 0 2 0 1 2 5
2022/202322 3 2 0 2 3 3 0 3 5 1 0 0
2023/2024116 4 2 8 0 4 9 1 2 10 15 10 51
2024/2025114 13 1 21 62 17 0 0 0 0 0 0 0
Totale 398